89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 1 filers reported holding 89BIO INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,550,222 | +139.1% | 489,004 | +193.4% | 0.00% | +100.0% |
| Q2 2023 | $3,158,302 | +886.3% | 166,665 | +692.7% | 0.00% | – |
| Q1 2023 | $320,226 | +64.4% | 21,026 | +37.4% | 0.00% | – |
| Q4 2022 | $194,794 | +118.9% | 15,302 | 0.0% | 0.00% | – |
| Q3 2022 | $89,000 | +14.1% | 15,302 | -25.9% | 0.00% | – |
| Q1 2022 | $78,000 | -76.0% | 20,663 | -16.7% | 0.00% | – |
| Q4 2021 | $325,000 | -33.3% | 24,809 | 0.0% | 0.00% | – |
| Q3 2021 | $487,000 | -58.6% | 24,809 | -60.5% | 0.00% | – |
| Q2 2021 | $1,176,000 | -16.4% | 62,846 | +5.8% | 0.00% | -100.0% |
| Q1 2021 | $1,407,000 | +5.4% | 59,380 | +8.5% | 0.00% | 0.0% |
| Q4 2020 | $1,335,000 | +29.9% | 54,751 | +36.7% | 0.00% | – |
| Q3 2020 | $1,028,000 | +64.7% | 40,048 | +28.0% | 0.00% | – |
| Q2 2020 | $624,000 | -14.3% | 31,286 | +8.6% | 0.00% | – |
| Q1 2020 | $728,000 | -2.3% | 28,805 | +1.7% | 0.00% | – |
| Q4 2019 | $745,000 | – | 28,336 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,416,948 | $176,277,677 | 3.47% |
| Orchard Capital Management, LLC | 542,879 | $8,382,052 | 3.10% |
| Artia Global Partners LP | 465,465 | $7,186,780 | 2.99% |
| Octagon Capital Advisors LP | 1,219,157 | $18,823,784 | 2.89% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,694,404 | $41,601,598 | 2.25% |
| University of Wisconsin Foundation | 126,516 | $1,953,407 | 2.24% |
| Tri Locum Partners LP | 249,571 | $3,853,376 | 1.23% |
| Endurant Capital Management LP | 82,153 | $1,268,442 | 1.14% |
| Parkman Healthcare Partners LLC | 363,553 | $5,613,258 | 1.03% |
| ACUTA CAPITAL PARTNERS, LLC | 1,000 | $1,523,000 | 1.02% |